Eleonora Teplinsky, MD

03/29/2026

Last year , and I published the results of our WISH-Breast survey in JCO Oncology Practice. where we surveyed over 1,000 women about sexual health after breast cancer.

At , Dr. Menn gave a fantastic talk on genitourinary syndrome of menopause where she shared some of the comments we received in our survey.

Bottom line: sexual health is a critical part of breast cancer care and should not be neglected. Let us know all your sexual health and cancer questions.

03/29/2026

My three tips for anyone starting chemotherapy:
⭐️ Ask about neuropathy risk and consider cooling gloves (cryotherapy), compression therapy, and check Vit D (low Vit D is linked w higher risk of neuropathy)
⭐️ Ask about cardiovascular 🫀 risk and what monitoring is needed
⭐️ Ask about risk of hair loss (alopecia) and discuss scalp cooling (cold capping)

Bonus: Know what pre-medications you will be getting and what you can take at home for side effects like nausea 🤢

What tips would you add or what questions do you have about ?

03/29/2026

Hello 👋 from Cleveland!

Here for the National Consortium of Breast Centers Conference to give two talks on:
1️⃣ supportive care/ toxicity (specifically focusing on neuropathy, hair loss, and fertility preservation) and

2️⃣ challenges in (brain metastases management, oligometastatic breast cancer, molecular testing and how we have conversations about goals of care).

Will do a Substack soon with highlights but let me know your questions and thoughts on these topics!

03/28/2026

Post run chat and a new Substack (drteplinsky.substack.com) discussing 2 new studies: 1) ctDNA in HER2+ and triple negative breast cancer and 2) PARP inhibitors in metastatic breast cancer (beyond just in those patients with BRCA mutations).

03/27/2026

✨New Interlude Podcast episode is here with ! Dani was diagnosed with breast cancer 8 years ago at age 30. She had surgery, chemotherapy and has been on endocrine therapy since that time. She has built an incredible community on social media with thousands of followers as she talks about what it means to be a young breast cancer, survivorship, the ups and downs and everything in between.

She describes it as “sharing the grey areas after cancer” and this is such an important conversation as the time after active treatment is often harder and more challenging than active treatment. She is open and honest about her experiences, empowering others in so many ways. We talk about all of this on today’s episode and it is truly a candid look into what breast cancer survivorship is really like, especially for someone diagnosed at a young age.

You can find the Interlude Podcast 🎙️anywhere you listen to podcasts!

03/27/2026

192. Danielle Trops (Breast Cancer Survivor and Survivorship Advocate)

Today's podcast episode is with Danielle Trops - also known as on Instagram. Dani was diagnosed with breast cancer 8 years ago when she was 30 years old. She had surgery, chemotherapy and has been on endocrine therapy since that time. She has built an incredible community on social media with thousands of followers as she talks about what it means to be a young breast cancer, survivorship, the ups and downs and everything in between....

Today’s podcast episode is with Danielle Trops – also known as on Instagram. Dani was diagnosed with breast cancer 8 years ago when she was 30 years old. She had surgery, che…

03/27/2026

An important article from about GLP-1 medications and cancer risk. Lots to break down here!

03/26/2026

‼️ New drug approval in platinum resistant ovarian cancer: relacorilant (in combination with nab-paclitaxel chemotherapy)! Approval is on the basis of the ROSELLA trial. The brand name is Lifyorli.

Platinum-resistant ovarian cancer is defined as progression

03/23/2026

A woman reached out with a question about being told she had a normal mammogram and what did that mean in terms of her breast density. Let’s break that down.

03/22/2026

Chemotherapy induced peripheral neuropathy is a common and significant side effect of chemotherapy. There are no medications to prevent neuropathy but there are important measures we can take before starting treatment to reduce the risk of neuropathy - specifically from taxane chemotherapy (docetaxel and paclitaxel). This week, I did a podcast with all about this topic - take a 🎧 for more info (you can find the episode wherever you listen to podcasts!). Let me know all your neuropathy questions!

03/21/2026

On today’s episode, I am speaking with . Heather was diagnosed with metastatic breast cancer at the age of 26 and has been living with MBC for 25 years. She is an incredible patient advocate and leader in the MBC community and is the host of the podcast,
“I’m Still Here: Real Conversations About Living with Metastatic Breast Cancer” which explores what life with metastatic breast cancer is truly like, focusing on topics such as relationships, identity, work, uncertainty, quality of life, and more.

Heather shares her experience living with metastatic breast cancer—from the initial diagnosis to what the past 25 years have truly looked like. We explore essential topics that are often under-discussed, including fertility and pregnancy after diagnosis, relationships, financial toxicity and work, and scanxiety. This conversation highlights the real-life challenges and experiences of those living with metastatic breast cancer.

You can find the Interlude Podcast anywhere you 🎧 to podcasts! Let me know what you think!

03/21/2026

191. Heather Jose (Living with Metastatic Breast Cancer for 25 Years)

On today's episode, I am speaking with Heather Jose. Heather was diagnosed with metastatic breast cancer at the age of 26 and has been living with MBC for 25 years. She is an incredible patient advocate and leader in the MBC community and is the host of the podcast, "I'm Still Here: Real Conversations About Living with Metastatic Breast Cancer…...

On today’s episode, I am speaking with Heather Jose. Heather was diagnosed with metastatic breast cancer at the age of 26 and has been living with MBC for 25 years. She is an incredible patie…